☰

Empresas y finanzas

CVS to buy pharmacy services provider Omnicare for $10.1 billion


    (Reuters) - CVS Health Corp , the second-largest U.S. drugstore operator, said on Thursday it will buy pharmacy services provider Omnicare Inc for $10.1 billion to expand in the market serving the elderly.

    CVS's $98 per share offer represents a premium of 4 percent to Omnicare's closing price on Wednesday.

    Omnicare's stock had risen 9.5 percent since April 30 when Bloomberg reported that the company was fielding takeover interest.

    Omnicare's shares rose 1.4 percent to $96 in premarket trading on Thursday. CVS stock was up about 2 percent at $103 in light trading.

    CVS said the deal valued Omnicare at about $12.7 billion, including debt of about $2.3 billion.

    Reuters reported on Wednesday that CVS was nearing a deal to buy Omnicare for more than $12 billion.

    CVS said it expects the deal to add about 20 cents to adjusted earnings per share in 2016.

    Barclays and Evercore are CVS's financial advisers, while Bank of America Merrill Lynch and Centerview Partners advised Omnicare.

    CVS's legal adviser is Sullivan & Cromwell LLP, while White & Case LLP served as Omnicare's legal counsel.

    (Reporting by Sruthi Ramakrishnan in Bengaluru; Editing by Sriraj Kalluvila)